Applications for the 21st Model List of Essential Medicines and the 7th Model List of Essential Medicines for Children Antibacterials Antibiotics for typhoid fever

被引：0
|
作者：
机构：
来源：
SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN) | 2019年 / 1021卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：19 / 26
页数：8
相关论文
共 46 条
  • [31] Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021
    Zhou, Yue
    Naci, Huseyin
    Chen, Dingyi
    Bai, Lin
    Shi, Luwen
    Guan, Xiaodong
    Wagner, Anita Katharina
    BMJ GLOBAL HEALTH, 2023, 8 (09):
  • [32] MODERN APPROACHES TO EVALUATION OF THE BIOEQUIVALENCE OF DRUGS BELONGING TO THE MODEL LIST OF VITALLY ESSENTIAL AND MOST IMPORTANT MEDICINES
    Smekhova, I. E.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2011, 44 (12) : 691 - 693
  • [33] Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
    Walsh, Jennifer
    Masini, Tiziana
    Huttner, Benedikt D.
    Moja, Lorenzo
    Penazzato, Martina
    Cappello, Bernadette
    PHARMACEUTICS, 2022, 14 (03)
  • [34] Refocusing the World Health Organization ' s Model List of Essential Medicines on the needs of low and middle income countries
    Wirtz, Veronika J.
    Gray, Andrew L.
    Sharma, Sangeeta
    Sun, Jing
    Hogerzeil, Hans, V
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 385 : e077776
  • [35] US drug shortages compared to the World Health Organization's Model List of Essential Medicines for Children: A cross-sectional study
    Patel, Ram
    Samiee-Zafarghandy, Samira
    Ziesenitz, Victoria
    Fox, Erin R.
    Anker, John van den
    Ong, Hilary
    Mazer-Amirshahi, Maryann
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 2012 - 2017
  • [36] Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic review
    Seneviwickrama, Maheeka
    Denagamagei, Sashini Shehana
    Jayakody, Surangi
    Gunasekera, Sanjeeva
    Liyanage, Guwani
    BMC CANCER, 2025, 25 (01)
  • [37] Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
    Lindenberg, M
    Kopp, S
    Dressman, JB
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 265 - 278
  • [38] Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications
    Freerks, Lisa
    Sommerfeldt, Jana
    Loeper, Pia C.
    Klein, Sandra
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 156 : 11 - 19
  • [39] Essentiality and economy: a feasibility approach to evaluating suggested revisions to the World Health Organization Model List of Essential Medicines for skin disease
    Joshi, T. P.
    Ren, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 1077 - 1077
  • [40] Addition of direct oral anticoagulants to the World Health Organization model list of essential medicines for the treatment of atrial fibrillation: An African perspective
    Noubiap, Jean Jacques
    Kamtchum-Tatuene, Joseph
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (07) : 3035 - 3038
12345